Calypte Only Company with Full Menu of Tests.

 

Support/Resistance
sogar mit unterstützung, damit es nur ganz langsam unter 0,10$ geht...schön langsam werden die longs gegrillt


      Type     Value     Conf.§
resist. 0.33 10
resist. 0.28 2
resist. 0.27 10
resist. 0.23 15
resist. 0.22 8
resist. 0.21 11
resist. 0.20 34
resist. 0.18 14
resist. 0.17 4
resist. 0.15 5
resist. 0.14 2
supp 0.13 4  

CALYPTE BIOMEDICAL - American Stock Exchange: HIV

Time & Sales most recent  next page
Rec. Time Action Price Volume

3:58:28 PM Bid 0.13 397000
3:57:58 PM Bid 0.13 356500
3:56:58 PM Bid 0.13 397000
3:56:48 PM Bid 0.13 356500
3:53:26 PM Bid 0.13 397000
3:51:06 PM Bid 0.13 394000
3:47:34 PM Bid 0.13 397000
3:40:04 PM Trade 0.14 3500
3:37:00 PM Trade 0.14 10000
3:35:24 PM Bid 0.13 447000
3:18:34 PM Bid 0.13 457000
3:12:36 PM Ask 0.14 75000
3:12:28 PM Ask 0.14 50500
3:12:26 PM Trade 0.14 500
3:08:06 PM Bid 0.13 437000
2:53:24 PM Bid 0.13 396500
2:49:50 PM Bid 0.13 389500
2:41:32 PM Ask 0.14 25000
2:38:08 PM Bid 0.13 388000
2:33:14 PM Bid 0.13 358000
2:30:44 PM Trade 0.14 600
2:30:42 PM Ask 0.14 112300
2:29:56 PM Bid 0.13 308000
 

Eigentlich unterhalte ich mich nicht mit Kaninchen...
Joelu du bist ja so geil aufs wetten, Mensch mach doch ein Wettbüro auf, vielleicht mit dem Slogan "Joelus Caly-Basher Remise" oder so ähnlich.
Nix für Ungut Joelu, Spaß muss sein.  

Sachlich austauschen könnten ...

Aus dem Yahoo Board


Dr. George's description of what is happening in China with the urine test...

CC August 15, 2005
We have previously made public the preliminary report from the Chinese CDC outlining the performance of the five tests that we included in the China clinical trial. Since the time of that report results from an additional 121 subjects were finalized and received from the Guangxi Province. Results from three of those subjects are in dispute and I am flying to China tomorrow to resolve the status of those subjects. Regardless of how this discussion turns out we continue to believe that all the tests meet the criteria of the SFDA for approval. Let me put this issue in perspective. When I announce the preliminary data from China I stated that the results from the blood and oral fluid assays were excellent. I also stated that the urine result, while less sensitive than the other two assays were good and met the performance required for approval. That remains true today. However, the three disputed samples are important to Calypte. We were required to test 275 HIV positive subjects in the China clinical trials, in the unlikely event we loose the dispute over the three samples three incorrect results can change the performance significantly when the sample size of known HIV positive subjects is small. In the case of blood and oral fluid the impact of these three samples would be unfortunate. But the results would still be very good. In the case of the urine rapid test the test would be approvable but would likely not qualify for expedited SFDA review. Regardless of the way these discussions transpire the fact remains that management and shareholders alike share a common goal - to receive approval and begin sales in China as soon as it is feasibly possible. ...

To achieve that goal and in the interest of time and expediency of the approval process I have made the following decision that has been endorsed by the Calypte Board and our China business partner The Marr Group. The first application that Calypte will file with the SFDA is intended to allow the SFDA is intended to allow the sales process to begin without any further delays or bureaucratic encumbrances. Therefore we have decided that our initial request for approval will be for the oral fluid rapid test. The performance of the oral fluid assay has been consistently excellent. We believe that the oral fluid assay submission will be accepted and quickly reviewed by the SFDA. The Chinese Government has expressed great interest in having an alternative to blood testing. We believe that the oral fluid assay squarely meets that need. Due to the magnitude of the HIV problem in China the Chinese Government has publicly committed to an aggressive testing program for its’ populous. They believe, and we concur, that adding oral fluid will make testing on the scale proposed for China possible and minimize the risk of infection for the thousands of health care professionals who conduct that testing. The decision to delay the submission of the urine assay was a difficult one but I believe the right one none the less. My concern is that submitting the application for approval of the urine rapid test simultaneously with the application for approval of the oral rapid test may slow down the approval process for both tests. I cannot allow that to happen. My decision is to get approval for the oral fluid assay as quickly as possible and get it on the Chinese market. Once that is done our R&D team can focus on making the adjustments necessary to bring the rapid urine test through a quick approval process. We will submit an application for market approval of our urine rapid test once we have completed our discussions related to the samples currently under debate and more importantly have strategically determined the appropriate path for getting our urine rapid test on the market. We have not abandoned our plans to seek and obtain approval for the urine rapid HIV test in China. Urine is a valuable alternative to blood testing and has a definite place in HIV testing and we have received verbal guidance from the SFDA that the urine rapid test is desirable and approvable.

thanks caranpaul



Anybody know about MedMira Inc?

Re:

This company made some nice deals in China and sells already good quality rapid tests. But they go "blood" only. At least a the moment.

With a good blood test they prove that making money in China is possible. I believe that this company will be successful in China in the future as well.

Is this dangerous for Calypte ?

I personally don't think so because of three reasons:

1) The market is huge, really huge. A lot more companies will be able to take their pieces from this cake without starving.

2) This company is a good example why Calypte goes "salive/urine". It will be quite hard to compete with all those blood tests on the market (legally and illegaly sold) by selling only blood tests as well. It is believed by the company that the saliva/urine will be the future. Imagine what would be possible for HIV when oral fluid becomes that the quasi-standard of testing during the next years. If the company can manage a proof-of-concept deal in one chinese province in 2006, I wouldn't completely rule out such a scenario to develop.

There are very obvious reasons why people will rather participate in oral testing than in a blood (or even urine)testing events from a medical institution. And testing as much people as possible is very important for generating a positive effect of such testing efforts.

3) I don't exclude that Medmira (and others) will come up with a non-blood test in the future too. They are not stupid too and will understand that this might become the future of mass screening. However, it seems that Calypte's tests (at least saliva, possibly even urine when those issues can get resolved) will hit the market much earlier than the ones of other companies.

All these regulatory nightmares with Chinese authorities will be experienced by any other company as well.




Gruß

C.O  

 

 

 

 

  ralph kabot :: zeitgeist :: mediengestalt

 

Betrachte jeden Tag, als den letzten deines Lebens.
Die Stunde , die du ersehnst , wird dich als willkommene Überraschung ereilen...





Gruß

C.O  

 

hier bringst !!!

#1208 "denn euer verhalten ist dem eines klardenkenden erwachsenen unwürid und führt es ad absurdum"

Wie wärs, wenn Du diese Aussage besser auf dich selbst beziehen würdest ?!

Dümer gehts (n)immer ...  

This board is going crazy. I'm long in half at .18 and the other half at .15. Down a couple of pennies but not worried.

Mobosux and Reads, although you have to wonder about their motives, are providing good input. I don't know exactly what their motive is and why they spend so much time providing negative info about the company if they indeed claim that they are not buying, not involved with short sellers and were not previously employed with the company. To think that they are hired by the competition is just a bit far-fetched. Just about as far-fetched as "truth, justice and the American way" as an explanation for why they spend so much time and effort on this board for no other purpose than providing information.

Anyhow, in response to Mobo's last post, here is some news from Adaltis:

http://adaltis.com/content/company/...tor_relations/news_releases.htm

http://adaltis.com/documents/news_releases/050307-english.pdf

They received orders to supply 1.5 million Rapid HIV tests from the Chinese govt for the Red Army some CDC centres and other customers in March of 2005. So, they are already selling rapid HIV tests in China. However, they are blood only.

I think the fact the Calypte will most likely be the first to be supplying Oral Rapid HIV testing is key. And, that they will be able to sell the blood, oral (and urine if the kinks are ironed out) from their factory in China gives them an advantage. Eventually, their work in Africa should start bearing fruit. I think MARR has showed that they aren't going to let Calypte go BK, I'm just concerned about further dilution. However, if they get some good news out soon, Calypte could pop very nicely.

Calypte is well-positioned right now and just needs to execute. With the HIV crisis as bad as it is now and considering that their ticker is HIV, if they get some good news rolling, you know how the buying hysteria can set in and how even worthless companies can go up huge. However, I don't think Calypte is a worthless company. They've got great potential if they get their product out there and start selling it. The scary part is the cash crunch in the meantime.

By the way, who the hell is STARK OFFSHORE MANAGEMENT, LLC and how did they end up with 10,000,000 shares as of March 31 2005?

http://www.quote.com/qc/research/topholders.aspx?symbols=AMEX:HIV
 

ONE OF THE INVESTORS
by: bruzzones2000 (49/F/California)  08/28/05 10:38 pm
Msg: 6799 of 6807

These are the holdings of Stark Offshore Management LLC as of March, 05. Mostly blue chip stocks with a little Calypte tossed in!

http://www.sec.gov/Archives/edgar/data/1307498/...05107422/d13fhr.txt

This company is operated by two former Harvard attorneys, who funded Alza, Delta Airlines and many other Fortune 500 Companies, Brian Stark and Michael Roth.

For more about them: http://www.hedgefundnews.com/news_n_info/article_detail.php?id=239

They operate as professional brokers to private investment groups.


 

GENERAL PATENT INFORMATION
by: bruzzones2000 (49/F/California)  08/28/05 10:49 pm
Msg: 6800 of 6807

JOINT OWNERSHIP OF PATENTS:
Patents may be owned jointly by two or more persons as in the case of a patent granted to joint inventors, or in the case of the assignment of a part interest in a patent. Any joint owner of a patent, no matter how small the part interest, may make, use, offer for sale and sell and import the invention for his or her own profit provided they do not infringe another’s patent rights, without regard to the other owners, and may sell the interest or any part of it, or grant licenses to others, without regard to the other joint owner, unless the joint owners have made a contract governing their relation to each other. It is accordingly dangerous to assign a part interest without a definite agreement between the parties as to the extent of their respective rights and their obligations to each other if the above result is to be avoided.

The owner of a patent may grant licenses to others. Since the patentee has the right to exclude others from making, using, offering for sale, or selling or importing the invention, no one else may do any of these things without his/her permission. A patent license agreement is in essence nothing more than a promise by the licensor not to sue the licensee. No particular form of license is required; a license is a contract and may include whatever provisions the parties agree upon, including the payment of royalties, etc.

The drawing up of a license agreement (as well as assignments) is within the field of an attorney at law. Such attorney should be familiar with patent matters as well. A few States have prescribed certain formalities to be observed in connection with the sale of patent rights.

PATENT INFRINGEMENT ONLY PERTAINS TO THE UNITED STATES:

Infringement of Patents
Infringement of a patent consists of the unauthorized making, using, offering for sale, or selling any patented invention within the United States or U.S. Territories, or importing into the United States of any patented invention during the term of the patent. If a patent is infringed, the patentee may sue for relief in the appropriate federal court. The patentee may ask the court for an injunction to prevent the continuation of the infringement and may also ask the court for an award of damages because of the infringement. In such an infringement suit, the defendant may raise the question of the validity of the patent, which is then decided by the court. The defendant may also aver that what is being done does not constitute infringement. Infringement is determined primarily by the language of the claims of the patent and, if what the defendant is making does not fall within the language of any of the claims of the patent, there is no literal infringement.

Suits for infringement of patents follow the rules of procedure of the federal courts. From the decision of the district court, there is an appeal to the Court of Appeals for the Federal Circuit. The Supreme Court may thereafter take a case by writ of certiorari. If the United States Government infringes a patent, the patentee has a remedy for damages in the United States Court of Federal Claims. The government may use any patented invention without permission of the patentee, but the patentee is entitled to obtain compensation for the use by or for the government. The Office has no jurisdiction over questions relating to infringement of patents. In examining applications for patent, no determination is made as to whether the invention sought to be patented infringes any prior patent. An improvement invention may be patentable, but it might infringe a prior unexpired patent for the invention improved upon, if there is one.

SOURCE: U.S. Patent Office
http://www.uspto.gov/web/offices/pac/doc/general/index.html

 

Der Junge heißt mit Vornamen Linda und ist ne Frau!  

 

U.S. to Help China Combat Surge in HIV By SARAH BRUMFIELD, Associated Press Writer
Mon Aug 29,10:34 AM ET

http://news.yahoo.com/s/ap/20050829/ap_on_he_me/us_china_aids

BALTIMORE - Chinese health officials on Monday plan to announce an  AIDS cooperation partnership with a U.S. institute, a measure that takes aim at combating what health officials fear will be a tenfold surge in HIV infection in China over the next five years.



The partnership between the Chinese Center for Disease Control and Prevention and the University of Maryland's Institute of Human Virology — founded by one of the co-discoverers of the virus — covers collaboration on clinical trials, technical assistance and development of better and faster tests and vaccines, institute officials said.

The step comes as  United Nations health officials warned in June that Asia's AIDS problem could rival sub-Saharan Africa if quick action is not taken to stem new infections.

There are 5.1 million people with the virus in India, second only to South Africa with 5.3 million infections, according to     UNAIDS estimates for 2003. About 840,000 people in China have the virus, according to the Chinese Ministry of Health, but the UN has warned that number could grow to 10 million by 2010 if the epidemic is left unchecked.

The Maryland institute, which combines laboratory research, epidemiology and clinical research in an effort to get new discoveries to the neediest, can help the Chinese develop strategies and help teach physicians about diagnosis and management of the disease, among other issues, said Richard Gallo, the institute's founder-director.

Other research will focus on the history of the disease in China and a study of traditional Chinese medicines for possible treatment.

The signing ceremony was planned for Monday, the first day of IHV's annual international AIDS meeting in Baltimore and was expected to include Gallo, China     CDC Director Wang Yu and Maryland Lt. Gov. Michael Steele.

While the Chinese CDC already sends researchers to the institute for training, the new agreement is expected to boost bilateral cooperation and allow American researchers to benefit from China's centuries old medical experience.

"This is more than just missionary work," Gallo said. "I think we have a real chance of getting help from China."

Under the program, institute researchers could also have greater access to non-human primates — which are more strictly controlled in the United States. They would also have access to tens of thousands of people for trials, said Gallo.

This partnership is the newest measure in the Chinese government's growing determination in recent years to fight the virus.

"In the mid-90s to late-90s, we know that the government recognized it as a problem, but they did not put enough priority on it," said Shao Yiming, chief expert for the National Center for AIDS/STD Control and Prevention, part of the Chinese CDC. "There was talking, but not real action."

One area where Maryland's Institute of Human Virology can help is with the organization of a nationwide campaign for prevention, testing and treatment of HIV and AIDS, Shao said. The government has increased funding to about $100 million (euro81.3 million) last year, so the challenge is implementing such an effort across a country with 1.3 billion people, Shao said.

"That doesn't mean that (Chinese health workers) are not technically good enough, they're just not so experienced with managing a national campaign at this level," he said. "We need an operational team, which is not in place on a large scale."

The institute is also working on a commercial expansion of this partnership with a three-way collaboration with the China CDC and CK Life Sciences, a Hong Kong-based pharmaceutical company, which they hope to sign sometime later this year, Gallo said.

___

On the Net:

Institute of Human Virology: http://www.ihv.org/

Chinese Center for Disease Control and Prevention: http://www.chinacdc.net.cn/

 

ohne, das sich bei HIV wirklich was tut. die berichte sind allgemein gehalten und könne auch trinity oder orasure dienen...aber naja, der fahrstuhl nach utnen ist jeden falls solange gebremst, bis neue negative fakten kommen, bzw, welche von den neuen aktien kommen. zu 0,14$ könnt ich wohl noch gut rauskommen....auf dauer geht es tiefer unter 0,10$. wer es nicht glauben will, soll es spüren...

die widerstände bei 0,18 bzw, 0,20 sind beträchtlich:


Support/Resistance
      Type     Value     Conf.§
resist. 0.33 10
resist. 0.28 2
resist. 0.27 10
resist. 0.23 15
resist. 0.22 8
resist. 0.21 11
resist. 0.20 34
resist. 0.18 13
resist. 0.17 4
resist. 0.15 5
supp 0.14 2
supp 0.13 4  

 

 

 

windest du dich immer noch? ich wollte mit den zitaten deiner kommentare nur nochmald dein feiges und unglaubwürdiges verhalten unter beweis stellen. der august ist fast vorbei und ihr seid bei:


Time & Sales most recent  next page
Rec. Time Action Price Volume
3:15:08 PM Ask 0.15 381000
3:15:06 PM Trade 0.15 15500
3:10:18 PM Ask 0.15 396500
2:46:22 PM Ask 0.15 230000
2:45:44 PM Bid 0.14 37200
2:42:36 PM Bid 0.14 27200
2:28:12 PM Bid 0.14 7200
2:28:10 PM Bid 0.14 4800
2:28:08 PM Ask 0.15 396500
2:28:08 PM Bid 0.14 7200
2:28:00 PM Ask 0.14 100
2:27:56 PM Trade 0.14 2800
2:25:20 PM Ask 0.14 2800
2:25:18 PM Trade 0.14 600
2:22:44 PM Trade 0.14 100
2:22:44 PM Trade 0.14 100
2:22:44 PM Trade 0.14 100
2:22:44 PM Trade 0.14 100
2:22:44 PM Trade 0.14 100
2:22:44 PM Trade 0.14 100
2:22:44 PM Ask 0.14 3400
2:22:44 PM Trade 0.14 100
2:22:44 PM Trade 0.14 100
2:22:44 PM Trade 0.14 100
2:22:44 PM Trade 0.14 100
2:22:44 PM Trade 0.14 100
2:22:44 PM Trade 0.14 100
2:22:44 PM Trade 0.14 100
2:22:44 PM Trade 0.14 100
2:22:44 PM Trade 0.14 100
2:22:44 PM Trade 0.14 100
2:22:44 PM Trade 0.14 100
2:22:44 PM Trade 0.14 100
2:22:44 PM Trade 0.14 100
2:22:44 PM Trade 0.14 100
2:22:44 PM Trade 0.14 100
2:22:44 PM Trade 0.14 100
2:22:44 PM Trade 0.14 100
2:22:44 PM Trade 0.14 100
2:22:44 PM Trade 0.14 100
2:22:44 PM Trade 0.14 100
2:22:44 PM Trade 0.14 100
2:22:44 PM Trade 0.14 100
2:22:44 PM Trade 0.14 100
2:22:44 PM Trade 0.14 100
2:22:44 PM Trade 0.14 100
2:22:44 PM Trade 0.14 100
2:22:44 PM Trade 0.14 100
2:22:44 PM Trade 0.14 100


wo sind die 5-6$ und wie lange sollen die verarschten noch darauf warten?  

sondern ich werde nur von dir verarscht gute Nacht !